Compare NRG Energy Inc (NRG) vs Sanofi SA (SNY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NRG Energy Inc vs Sanofi SA — how do they compare? NRG Energy Inc trades at $116.71 (market cap $24.25B), while Sanofi SA trades at $43.12 (market cap $103.41B). The key difference: Sanofi SA is far larger — about 4.3× NRG Energy Inc's market cap, and Sanofi SA pays the higher dividend (5.65%). Which is the better fit depends on your goals.
| NRG | SNY | |
|---|---|---|
Market Cap | $24.25B | $103.41B |
Sector | Utilities | Health |
52-Week High | $184.03 | $52.34 |
52-Week Low | $109.51 | $41.33 |
Enterprise Value | $48.21B | $123.44B |
Dividend Yield | 1.65% | 5.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NRG Energy trades at $119.64, up 0.52% on the day, with a bullish technical signal and key support at $118. Recent Q2 2026 earnings missed estimates, but revenue grew 11% year-over-year. The company is pursuing growth via a 1.2 GW Texas data center power project and reaffirmed 2026 guidance, while analyst consensus remains strongly positive with a $201.29 price target.
The outlook is supported by strategic investments in data center demand and shareholder returns, but risks include rising interest costs, high leverage, and execution challenges. The stock offers significant upside to analyst targets if growth initiatives deliver, though near-term volatility may persist amid earnings misses and macroeconomic pressures.
SNY trades at $43.16, down 2.45% today, with a bearish technical signal from moving averages but bullish oscillators. The company reported Q2 2026 EPS of $1.21, beating expectations, and raised its 2026 outlook driven by Dupixent strength. Financials show improved net income of $7.81B in 2025, with a P/E of 22.94 and net margin of 8.09%.
Outlook is mixed: strong drug performance and analyst hold ratings suggest stability, but pipeline setbacks and projected 2026 profit margin decline to 8.09% pose risks. The stock offers a 5.4% dividend yield, trading below sector P/E, presenting value if growth execution offsets challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About NRG Energy Inc
NRG Energy is one of the largest retail energy providers in the U.S., with 7 million customers, including its 2021 acquisition of Direct Energy. It also is one of the largest U.S. independent power producers, with 16 gigawatts of nuclear, coal, gas, and oil power generation capacity primarily in Texas. Since 2018, NRG has divested its 47% stake in NRG Yield, among other renewable energy and conventional generation investments. NRG exited Chapter 11 bankruptcy as a stand-alone entity in December 2003.
Read more on NRG →About Sanofi SA
Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.
Read more on SNY →
